JP2007530676A5 - - Google Patents

Download PDF

Info

Publication number
JP2007530676A5
JP2007530676A5 JP2007506137A JP2007506137A JP2007530676A5 JP 2007530676 A5 JP2007530676 A5 JP 2007530676A5 JP 2007506137 A JP2007506137 A JP 2007506137A JP 2007506137 A JP2007506137 A JP 2007506137A JP 2007530676 A5 JP2007530676 A5 JP 2007530676A5
Authority
JP
Japan
Prior art keywords
mesoporphyrin
metal
halide
temperature
formate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506137A
Other languages
English (en)
Japanese (ja)
Other versions
JP4939398B2 (ja
JP2007530676A (ja
Filing date
Publication date
Priority claimed from US10/812,156 external-priority patent/US7375216B2/en
Application filed filed Critical
Publication of JP2007530676A publication Critical patent/JP2007530676A/ja
Publication of JP2007530676A5 publication Critical patent/JP2007530676A5/ja
Application granted granted Critical
Publication of JP4939398B2 publication Critical patent/JP4939398B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007506137A 2004-03-29 2004-11-24 金属メソポルフィリンハライド化合物の調製 Expired - Fee Related JP4939398B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/812,156 2004-03-29
US10/812,156 US7375216B2 (en) 2002-06-04 2004-03-29 Preparation of metal mesoporphyrin compounds
PCT/US2004/039240 WO2005103056A2 (en) 2004-03-29 2004-11-24 Preparation of metal mesoporphyrin halide compounds

Publications (3)

Publication Number Publication Date
JP2007530676A JP2007530676A (ja) 2007-11-01
JP2007530676A5 true JP2007530676A5 (https=) 2008-01-10
JP4939398B2 JP4939398B2 (ja) 2012-05-23

Family

ID=35197536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506137A Expired - Fee Related JP4939398B2 (ja) 2004-03-29 2004-11-24 金属メソポルフィリンハライド化合物の調製

Country Status (5)

Country Link
US (3) US7375216B2 (https=)
EP (1) EP1730150A4 (https=)
JP (1) JP4939398B2 (https=)
CA (1) CA2561487C (https=)
WO (1) WO2005103056A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
EP1865777A4 (en) * 2005-04-01 2008-07-16 Infacare Pharmaceutical Corp STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
US20070077480A1 (en) * 2005-10-05 2007-04-05 Curello Andrew J Scavenger materials in fuel cartridge
US20080113955A1 (en) * 2006-10-04 2008-05-15 Benjamin Levinson Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
US7960371B2 (en) * 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
IT1403087B1 (it) * 2010-11-05 2013-10-04 Lombardi Catalizzatori ad alta efficienza, loro preparazione e uso
PL2691398T3 (pl) 2011-03-30 2017-07-31 Infacare Pharmaceutical Corporation Sposoby syntezy mezoporfiryn metali
AU2012345646A1 (en) 2011-12-01 2014-06-26 Infacare Pharmaceutical Corporation Methods for treating hyperbilirubinemia with stannsoporfin
CN103193783A (zh) * 2013-03-29 2013-07-10 甘肃农业大学 一种以牦牛血粉为原料制备氯化血红素的方法
SI3200582T1 (sl) 2014-09-29 2024-04-30 Fred Hutchinson Cancer Center Sestave, kompleti in metode za indukcijo pridobljene citorezistence z uporabo induktorjev stresnih proteinov

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684637A (en) * 1981-07-15 1987-08-04 The Rockefeller University Method of decreasing rate of heme metabolism
JPS58501130A (ja) 1981-07-15 1983-07-14 ザ　ロツクフエラ−　ユニバ−シテイ ヘムの代謝速度の低下方法
US4708964A (en) * 1984-02-09 1987-11-24 Chemex Pharmaceuticals Lipoxygenase inhibitors
AU570143B2 (en) 1985-01-14 1988-03-03 Rockefeller University, The Method of increasing heme excretion from a mammal using tin protoporphyrin
US4619923A (en) * 1985-01-14 1986-10-28 The Rockefeller University Metal protoporphyrins in the control of tryptophan metabolism
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4692440A (en) * 1985-03-25 1987-09-08 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4692439A (en) * 1986-06-20 1987-09-08 The Rockefeller University Therapeutic use of tin diiododeuteroporphyrin
US4668670A (en) * 1986-06-20 1987-05-26 The Rockefeller University Tin diiododeuteroporphyrin and therapeutic use thereof
US4861876A (en) * 1986-11-26 1989-08-29 Wayne State University Hematoporphyrin derivative and method of preparation and purification
US4782049A (en) * 1986-12-08 1988-11-01 The Rockefeller University Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
US4900871A (en) * 1987-01-02 1990-02-13 Sun Refining And Marketing Company Hydrocarbon oxidations catalyzed by iron coordination complexes containing a halogenated ligand
US5990363A (en) * 1987-01-02 1999-11-23 Sun Company, Inc. Method for oxidizing alkanes using novel porphyrins synthesized from dipyrromethanes and aldehydes
WO1989002269A1 (en) 1987-09-08 1989-03-23 The Rockefeller University Use of metalloporphyrins to reverse the toxic effect of tumor therapy
US5081115A (en) * 1987-10-15 1992-01-14 The Board Of Trustees Of The Leland Stanford Junior University Method to prevent neonatal jaundice with metalloporphyrin compositions
US4831024A (en) * 1987-10-15 1989-05-16 The Board Of Trustees Of The Leland Stanford Junior University Method to prevent neonatal jaundice
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5162313A (en) * 1989-03-16 1992-11-10 The Rockefeller University Control of heme and iron concentrations in body tissues
US5223494A (en) * 1989-09-25 1993-06-29 The Rockefeller University Orally administered porphyrins to control intestinal iron absorption
US5062775A (en) * 1989-09-29 1991-11-05 Rocky Mountain Research, Inc. Roller pump in an extra corporeal support system
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5192757A (en) * 1990-12-20 1993-03-09 Glaxo Inc. Cobalt porphyrins
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
WO1994028906A1 (en) 1993-06-14 1994-12-22 The Rockefeller University Treatment of neonatal hyperbilirubin with metalloporphyrin
CA2130853A1 (en) * 1994-08-25 1996-02-26 Svetlana Kudrevich Process for the syntheses of monosulphonated phthalocyanines, naphthobenzoporphyrazines and porphyrins via a modified meerwein reaction
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5912341A (en) * 1995-03-14 1999-06-15 Hoffman/Barrett, L.L.C. Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
WO1997005152A1 (en) 1995-08-02 1997-02-13 Warner-Lambert Company Amino acid complexes of cobalt (iii) mesoporphyrin ix and cobalt (iii) protoporphyrin ix
US5883246A (en) * 1996-03-07 1999-03-16 Qlt Phototherapeutics, Inc. Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
US6004530A (en) * 1996-06-04 1999-12-21 Roche Diagnostics Gmbh Use of metallo-porphyrin conjugates for the detection of biological substances
GB9616353D0 (en) * 1996-08-03 1996-09-11 Secr Defence Metallo-porphyrins
US6124452A (en) * 1997-12-19 2000-09-26 University Of Nebraska-Lincoln Octafluoro-meso-tetraarylporphyrins and methods for making these compounds
DE19706490C1 (de) * 1997-02-19 1998-09-17 Deutsches Krebsforsch Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen
US5886173A (en) * 1997-07-30 1999-03-23 Pharmacyclics, Inc. Metallation of macrocycles with 2,4-dicarbonyl-metal complexes
US6194566B1 (en) * 1997-12-02 2001-02-27 Schering Aktiengesellschaft Process for the production of metalloporphyrin-metal complex conjugates
JP3673888B2 (ja) * 1998-03-09 2005-07-20 独立行政法人科学技術振興機構 ポルフィリン類金属錯体の製造方法
DE19831217A1 (de) * 1998-07-03 2000-01-05 Schering Ag Neue Porphyrinderivate, diese enthaltende pharmazeutische Mittel und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik
US5973141A (en) * 1998-11-27 1999-10-26 Miravant Pharmaceuticals, Inc. Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides
JP2003526668A (ja) 2000-03-10 2003-09-09 ザ ロックフェラー ユニバーシティー 心臓血管損傷の調節
US6462192B2 (en) * 2001-01-23 2002-10-08 Miravant Pharmaceuticals, Inc. Processes for large scale production of tetrapyrroles
CA2448570A1 (en) 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
US7375216B2 (en) 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
AU2003237349B2 (en) * 2002-06-04 2010-06-03 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds
US20040097481A1 (en) 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
DE602004019761D1 (de) * 2003-01-08 2009-04-16 Novartis Vaccines & Diagnostic Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
EP1865777A4 (en) 2005-04-01 2008-07-16 Infacare Pharmaceutical Corp STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
US20080113955A1 (en) * 2006-10-04 2008-05-15 Benjamin Levinson Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
US7960371B2 (en) * 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin

Similar Documents

Publication Publication Date Title
JP2007530676A5 (https=)
CN106554324B (zh) 基于咪唑盐型配体的金属有机框架材料及制备方法与应用
JP2009530445A5 (https=)
JP2005528444A5 (https=)
CN108435255A (zh) 一种铱单原子催化剂及其制备方法与应用
CN104448381A (zh) 咪唑功能化有序介孔酚醛树脂材料的制备及其应用
CA2561487A1 (en) Preparation of metal mesoporphyrin halide compounds
CN113582812B (zh) 一种液相催化制备氯乙烯的方法
CN113527188A (zh) 一种制备间位官能团化的吡啶化合物的方法
CN111732535B (zh) 杂芳基胺类化合物的光化学合成方法
CA2487426A1 (en) Preparation of metal mesoporphyrin halide compounds
CN112778218A (zh) 一种壳聚糖负载铜催化剂制备喹唑酮及其衍生物的方法
Shaikh et al. Halide perovskite induces halogen/hydrogen atom transfer (XAT/HAT) for allylic C− H amination
CN101940953A (zh) 一种乙炔二聚非水体系催化剂及制备乙烯基乙炔的方法
CN109622037B (zh) 一种Pd@Co4(tpt)2(btb)复合材料及其制备方法和应用
CN111072492A (zh) 一种合成3,4-二氯-2-氨基-5-氟联苯的方法
CN108610263A (zh) 一种以硼氨烷为氢源催化加氢合成葡甲胺的方法
CN101182304B (zh) 吡咯烷或n-烷基吡咯烷的制备方法
CN119684251A (zh) 一种碳酸亚乙烯酯的制备方法
CN109701574B (zh) 氮修饰炭载贵金属加氢催化剂的制备和在吡啶环类化合物加氢反应中的应用
CN111068729A (zh) 一种磷掺杂或氮掺杂多壁碳纳米管催化剂及其制备方法与应用
CN111359649A (zh) 一步法制备果壳基氮掺杂活性炭催化剂、产品及应用
CN105753738A (zh) 一种硝基苯甲腈催化加氢合成氨基苯甲腈的方法
CN107382741A (zh) 催化炔烃和胺的分子间氢胺化反应的方法
CN114807616A (zh) 一种从含钯有机废液中回收富集钯的方法